Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials.

Kahn SR, Diendéré G, Morrison DR, Piché A, Filion KB, Klil-Drori AJ, Douketis J, Emed J, Roussin A, Tagalakis V, Morris M, Geerts W.

BMJ Open. 2019 May 24;9(5):e024444. doi: 10.1136/bmjopen-2018-024444.

2.

External Validation of ASPECT (Algorithm for Suspected Pulmonary Embolism Confirmation and Treatment).

Klil-Drori AJ, Prajapati D, Liang Z, Wang M, Toupin D, Alothman L, Lang E, Suryanarayan D, Tagalakis V.

Med Care. 2019 Aug;57(8):e47-e52. doi: 10.1097/MLR.0000000000001055.

PMID:
30608277
3.

Sex may matter when it comes to the presenting location of deep vein thrombosis.

Tagalakis V.

Thromb Res. 2019 Jan;173:164-165. doi: 10.1016/j.thromres.2018.12.001. Epub 2018 Dec 6. No abstract available.

PMID:
30545613
4.

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.

Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S, Schattner A, Kuruvilla P, Hill D, Spadafora S, Marquis K, Trinkaus M, Tomiak A, Lee AYY, Gross PL, Lazo-Langner A, El-Maraghi R, Goss G, Le Gal G, Stewart D, Ramsay T, Rodger M, Witham D, Wells PS; AVERT Investigators.

N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4.

PMID:
30511879
5.

Treatment algorithm in cancer-associated thrombosis: Canadian expert consensus.

Carrier M, Blais N, Crowther M, Kavan P, Le Gal G, Moodley O, Shivakumar S, Tagalakis V, Wu C, Lee AYY.

Curr Oncol. 2018 Oct;25(5):329-337. doi: 10.3747/co.25.4266. Epub 2018 Oct 31.

6.

Risk of Thromboembolic Disease With Cost Estimates in Patients Undergoing Robotic Assisted Surgery for Endometrial Cancer and Review of the Literature.

Laskov I, Kessous R, Abitbol J, Kogan L, Badeghiesh A, Tagalakis V, Cohen S, Salvador S, Lau S, Gotlieb WH; SOGC Communities of Practice.

J Obstet Gynaecol Can. 2018 Dec;40(12):1571-1579. doi: 10.1016/j.jogc.2018.04.003. Epub 2018 Sep 24.

PMID:
30262383
7.

Hemolytic anemia in a 26-year-old woman with vomiting and fatigue.

Elharram M, Sapon-Cousineau V, Tagalakis V.

CMAJ. 2018 Aug 27;190(34):E1013-E1017. doi: 10.1503/cmaj.171147. No abstract available.

PMID:
30150243
8.

Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.

Kahn SR, Morrison DR, Diendéré G, Piché A, Filion KB, Klil-Drori AJ, Douketis JD, Emed J, Roussin A, Tagalakis V, Morris M, Geerts W.

Cochrane Database Syst Rev. 2018 Apr 24;4:CD008201. doi: 10.1002/14651858.CD008201.pub3. Review.

PMID:
29687454
9.

Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study.

van Es N, Louzada M, Carrier M, Tagalakis V, Gross PL, Shivakumar S, Rodger MA, Wells PS.

Thromb Res. 2018 Mar;163:41-46. doi: 10.1016/j.thromres.2018.01.009. Epub 2018 Jan 9.

PMID:
29353682
10.

Direct Oral Anticoagulants in End-Stage Renal Disease.

Klil-Drori AJ, Tagalakis V.

Semin Thromb Hemost. 2018 Jun;44(4):353-363. doi: 10.1055/s-0037-1621715. Epub 2018 Jan 10. Review.

PMID:
29320795
11.

Temporal trends in outpatient management of incident pulmonary embolism and associated mortality.

Klil-Drori AJ, Coulombe J, Suissa S, Hirsch A, Tagalakis V.

Thromb Res. 2018 Jan;161:111-116. doi: 10.1016/j.thromres.2017.10.026. Epub 2017 Nov 6.

PMID:
29132688
12.

Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism.

Godin R, Marcoux V, Tagalakis V.

Vascul Pharmacol. 2017 Aug;93-95:1-5. doi: 10.1016/j.vph.2017.05.001. Epub 2017 May 4. Review.

PMID:
28479313
13.

A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2).

Davies GA, Lazo-Langner A, Gandara E, Rodger M, Tagalakis V, Louzada M, Corpuz R, Kovacs MJ.

Thromb Res. 2018 Feb;162:88-92. doi: 10.1016/j.thromres.2017.04.003. Epub 2017 Apr 6.

PMID:
28416213
14.

Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.

Larivée N, Suissa S, Coulombe J, Tagalakis V, Filion KB.

Drug Saf. 2017 Jul;40(7):583-596. doi: 10.1007/s40264-017-0525-2.

PMID:
28382493
15.

Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies.

Larivée N, Suissa S, Khosrow-Khavar F, Tagalakis V, Filion KB.

BJOG. 2017 Sep;124(10):1490-1499. doi: 10.1111/1471-0528.14623. Epub 2017 May 5. Erratum in: BJOG. 2018 Jun;125(7):910.

16.

Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.

Coyle K, Carrier M, Lazo-Langner A, Shivakumar S, Zarychanski R, Tagalakis V, Solymoss S, Routhier N, Douketis J, Coyle D.

Thromb Res. 2017 Mar;151:67-71. doi: 10.1016/j.thromres.2017.01.007. Epub 2017 Jan 25.

PMID:
28160670
17.

A multicenter prospective study of risk factors and treatment of unusual site thrombosis.

Ma K, Wells P, Guzman C, Anderson D, Blostein M, Hirsch A, Lazo-Langner A, Kovacs MJ, Rodger M, Tagalakis V, Kahn SR.

Thromb Res. 2016 Aug;144:100-5. doi: 10.1016/j.thromres.2016.04.014. Epub 2016 Apr 26.

PMID:
27318246
18.

Incidence Trends and Mortality from Childhood Venous Thromboembolism: A Population-Based Cohort Study.

Sabapathy CA, Djouonang TN, Kahn SR, Platt RW, Tagalakis V.

J Pediatr. 2016 May;172:175-180.e1. doi: 10.1016/j.jpeds.2016.02.017. Epub 2016 Mar 3.

PMID:
26947569
19.

Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study.

Tagalakis V, Eberg M, Kahn S, Azoulay L.

Thromb Haemost. 2016 Jun 2;115(6):1220-8. doi: 10.1160/TH15-10-0775. Epub 2016 Jan 28.

PMID:
26819144
20.

Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism.

Ihaddadene R, Corsi DJ, Lazo-Langner A, Shivakumar S, Zarychanski R, Tagalakis V, Solymoss S, Routhier N, Douketis J, Le Gal G, Carrier M.

Blood. 2016 Apr 21;127(16):2035-7. doi: 10.1182/blood-2015-11-682963. Epub 2016 Jan 27.

21.

Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism.

Klil-Drori AJ, Yin H, Tagalakis V, Aprikian A, Azoulay L.

Eur Urol. 2016 Jul;70(1):56-61. doi: 10.1016/j.eururo.2015.06.022. Epub 2015 Jun 29.

PMID:
26138040
22.

Screening for Occult Cancer in Unprovoked Venous Thromboembolism.

Carrier M, Lazo-Langner A, Shivakumar S, Tagalakis V, Zarychanski R, Solymoss S, Routhier N, Douketis J, Danovitch K, Lee AY, Le Gal G, Wells PS, Corsi DJ, Ramsay T, Coyle D, Chagnon I, Kassam Z, Tao H, Rodger MA; SOME Investigators.

N Engl J Med. 2015 Aug 20;373(8):697-704. doi: 10.1056/NEJMoa1506623. Epub 2015 Jun 22.

23.

Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment.

Easaw JC, Shea-Budgell MA, Wu CM, Czaykowski PM, Kassis J, Kuehl B, Lim HJ, MacNeil M, Martinusen D, McFarlane PA, Meek E, Moodley O, Shivakumar S, Tagalakis V, Welch S, Kavan P.

Curr Oncol. 2015 Apr;22(2):144-55. doi: 10.3747/co.22.2587.

24.

Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis.

Easaw JC, Shea-Budgell MA, Wu CM, Czaykowski PM, Kassis J, Kuehl B, Lim HJ, MacNeil M, Martinusen D, McFarlane PA, Meek E, Moodley O, Shivakumar S, Tagalakis V, Welch S, Kavan P.

Curr Oncol. 2015 Apr;22(2):133-43. doi: 10.3747/co.22.2586.

25.

Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendations.

Carrier M, Lazo-Langner A, Shivakumar S, Tagalakis V, Gross PL, Blais N, Butts CA, Crowther M.

Curr Oncol. 2015 Feb;22(1):49-59. doi: 10.3747/co.22.2392.

26.

Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome.

Rabinovich A, Cohen JM, Cushman M, Wells PS, Rodger MA, Kovacs MJ, Anderson DR, Tagalakis V, Lazo-Langner A, Solymoss S, Miron MJ, Yeo E, Smith R, Schulman S, Kassis J, Kearon C, Chagnon I, Wong T, Demers C, Hanmiah R, Kaatz S, Selby R, Rathbun S, Desmarais S, Opatrny L, Ortel TL, Ginsberg JS, Kahn SR.

J Thromb Haemost. 2015 Mar;13(3):398-408. doi: 10.1111/jth.12814. Epub 2015 Feb 10.

27.

Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial.

Kahn SR, Shapiro S, Ducruet T, Wells PS, Rodger MA, Kovacs MJ, Anderson D, Tagalakis V, Morrison DR, Solymoss S, Miron MJ, Yeo E, Smith R, Schulman S, Kassis J, Kearon C, Chagnon I, Wong T, Demers C, Hanmiah R, Kaatz S, Selby R, Rathbun S, Desmarais S, Opatrny L, Ortel TL, Galanaud JP, Ginsberg JS.

Thromb Haemost. 2014 Dec;112(6):1137-41. doi: 10.1160/TH14-05-0430. Epub 2014 Aug 28.

PMID:
25183442
28.

Treatment patterns of venous thromboembolism in a real-world population: the Q-VTE study cohort.

Tagalakis V, Patenaude V, Kahn SR, Suissa S.

Thromb Res. 2014 Oct;134(4):795-802. doi: 10.1016/j.thromres.2014.07.002. Epub 2014 Jul 10.

PMID:
25135794
29.

The risk of thromboembolic events in kidney transplant patients.

Verhave JC, Tagalakis V, Suissa S, Madore F, Hébert MJ, Cardinal H.

Kidney Int. 2014 Jun;85(6):1454-60. doi: 10.1038/ki.2013.536. Epub 2014 Jan 15.

30.

Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants.

Wharin C, Tagalakis V.

Blood Rev. 2014 Jan;28(1):1-8. doi: 10.1016/j.blre.2013.11.001. Epub 2013 Nov 28. Review.

PMID:
24360911
31.

Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial.

Kahn SR, Shapiro S, Wells PS, Rodger MA, Kovacs MJ, Anderson DR, Tagalakis V, Houweling AH, Ducruet T, Holcroft C, Johri M, Solymoss S, Miron MJ, Yeo E, Smith R, Schulman S, Kassis J, Kearon C, Chagnon I, Wong T, Demers C, Hanmiah R, Kaatz S, Selby R, Rathbun S, Desmarais S, Opatrny L, Ortel TL, Ginsberg JS; SOX trial investigators.

Lancet. 2014 Mar 8;383(9920):880-8. doi: 10.1016/S0140-6736(13)61902-9. Epub 2013 Dec 6.

PMID:
24315521
32.

Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.

Kahn SR, Morrison DR, Cohen JM, Emed J, Tagalakis V, Roussin A, Geerts W.

Cochrane Database Syst Rev. 2013 Jul 16;(7):CD008201. doi: 10.1002/14651858.CD008201.pub2. Review. Update in: Cochrane Database Syst Rev. 2018 Apr 24;4:CD008201.

PMID:
23861035
33.

Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort.

Tagalakis V, Patenaude V, Kahn SR, Suissa S.

Am J Med. 2013 Sep;126(9):832.e13-21. doi: 10.1016/j.amjmed.2013.02.024. Epub 2013 Jul 3.

PMID:
23830539
34.

Risk of prostate cancer death in long-term users of warfarin: a population-based case-control study.

Tagalakis V, Tamim H, Blostein M, Hanley JA, Kahn SR.

Cancer Causes Control. 2013 Jun;24(6):1079-85. doi: 10.1007/s10552-013-0185-1. Epub 2013 Mar 15.

PMID:
23494728
35.

Comprehensive update on the prevention and treatment of venous thromboembolism in cancer patients.

Tagalakis V, Wharin C, Kahn SR.

Semin Thromb Hemost. 2013 Mar;39(2):127-40. doi: 10.1055/s-0032-1333537. Epub 2013 Feb 5. Review.

PMID:
23386467
36.

Assessing suitability for short-term cognitive-behavioral therapy in psychiatric outpatients with psychosis: a comparison with depressed and anxious outpatients.

Myhr G, Russell JJ, Saint-Laurent M, Tagalakis V, Belisle D, Khodary F, Faridi K, Pinard G.

J Psychiatr Pract. 2013 Jan;19(1):29-41. doi: 10.1097/01.pra.0000426325.49396.4c.

PMID:
23334677
37.

The occurrence of venous thromboembolism in cancer patients following major surgery.

Toledano TH, Kondal D, Kahn SR, Tagalakis V.

Thromb Res. 2013 Jan;131(1):e1-5. doi: 10.1016/j.thromres.2012.10.014. Epub 2012 Nov 20.

PMID:
23174626
38.

Men had a higher risk of recurrent venous thromboembolism than women: a large population study.

Tagalakis V, Kondal D, Ji Y, Boivin JF, Moride Y, Ciampi A, Kahn SR.

Gend Med. 2012 Feb;9(1):33-43. doi: 10.1016/j.genm.2011.12.002.

PMID:
22333521
39.

Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database.

Tagalakis V, Kahn SR.

Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):304-7. doi: 10.1002/pds.2061. Epub 2010 Dec 30.

PMID:
21351312
40.

The risk of venous thrombosis, including cerebral vein thrombosis, among women with thrombophilia and oral contraceptive use: a meta-analysis.

Dayan N, Holcroft CA, Tagalakis V.

Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E141-52. doi: 10.1177/1076029610391652. Epub 2011 Jan 10.

PMID:
21220364
41.

An assessment of surgical thromboprophylaxis in a tertiary care center.

Robinson-Cohen C, Pilon D, Dubois MF, Tagalakis V.

Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E39-45. doi: 10.1177/1076029610382652. Epub 2010 Sep 9.

PMID:
20829273
42.

The effect of warfarin use on clinical stage and histological grade of prostate cancer.

Tagalakis V, Tamim H.

Pharmacoepidemiol Drug Saf. 2010 May;19(5):436-9. doi: 10.1002/pds.1943.

PMID:
20437456
43.

Validating a method that deals with missing drug information in the Saskatchewan Drug Plan database.

Tamim HM, Tagalakis V.

Pharmacoepidemiol Drug Saf. 2009 Feb;18(2):140-6. doi: 10.1002/pds.1692.

PMID:
19090502
44.

Re: new developments in cognitive-behavioural therapy for mood disorders.

Coupland J, Morrison J, Myrh G, Pinard G, Racine H, Tagalakis V, St-Laurent M, Talbot J.

Can J Psychiatry. 2008 Jun;53(6):408. No abstract available.

PMID:
18616862
45.

High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients.

Tagalakis V, Levi D, Agulnik JS, Cohen V, Kasymjanova G, Small D.

J Thorac Oncol. 2007 Aug;2(8):729-34.

46.

Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial.

Kahn SR, Shbaklo H, Shapiro S, Wells PS, Kovacs MJ, Rodger MA, Anderson DR, Ginsberg JS, Johri M, Tagalakis V; SOX Trial Investigators.

BMC Cardiovasc Disord. 2007 Jul 24;7:21.

47.

Use of warfarin and risk of urogenital cancer: a population-based, nested case-control study.

Tagalakis V, Tamim H, Blostein M, Collet JP, Hanley JA, Kahn SR.

Lancet Oncol. 2007 May;8(5):395-402.

PMID:
17466896
48.

The effect of anticoagulants on cancer risk and survival: systematic review.

Tagalakis V, Blostein M, Robinson-Cohen C, Kahn SR.

Cancer Treat Rev. 2007 Jun;33(4):358-68. Epub 2007 Apr 3. Review.

PMID:
17408861
49.

A comprehensive view of sex-specific issues related to cardiovascular disease.

Pilote L, Dasgupta K, Guru V, Humphries KH, McGrath J, Norris C, Rabi D, Tremblay J, Alamian A, Barnett T, Cox J, Ghali WA, Grace S, Hamet P, Ho T, Kirkland S, Lambert M, Libersan D, O'Loughlin J, Paradis G, Petrovich M, Tagalakis V.

CMAJ. 2007 Mar 13;176(6):S1-44. Review. Erratum in: CMAJ. 2007 Apr 24;176(9):1310.

50.

Social skills training for adolescents with Asperger syndrome and high-functioning autism.

Tse J, Strulovitch J, Tagalakis V, Meng L, Fombonne E.

J Autism Dev Disord. 2007 Nov;37(10):1960-8. Epub 2007 Jan 11.

PMID:
17216559

Supplemental Content

Loading ...
Support Center